Health Industry Forum - Health and Healthcare Policy

Recent Conferences

April 4, 2006

Improving Evidence for Decision Making: Future Strategies for U.S. Technology Assessment

There has been growing interest among policymakers in establishing or funding a more extensive health technology assessment (HTA) capability in the U.S. similar to initiatives underway in other developed countries. This conference began with an overview of HTA in the U.S., and in Europe. It then examined practical challenges of evidence development and of using evidence for decision making from the perspective of both payers and patients. Participants engaged in a broad debate about potential opportunities and concerns about funding an expanded HTA capacity in the U.S.

Presentations:

Conceptualizing and Combining Evidence for Health System Guidance
Marc Berger, M.D., Vice President, Outcomes Research and Management, Merck & Co.
Should the US Establish a Coordinated Technology AssessmentCapability? How Should Future Efforts be Organized
Carolyn Clancy, M.D., Director, Agency for Healthcare Quality and Research
Considerations in Determining Effectiveness for Clinical and Payment Consideration
Barbara McNeil, M.D., Ph.D., Professor, Harvard Medical School
Technology Assessment in the U.S.
Steven Pearson, M.D., MSc, Special Advisor, Technology and Coverage Policy, Centers for Medicare and Medicaid Services
Technology Assessment in Europe and the U.K.
Sir Michael Rawlins, M.D., Chairman, National Institute for Clinical Excellence
A Payer Perspective on Improving Evidence for Decision Making: Future Strategies for U.S. Technology Assessment
Alan Rosenberg, M.D., Vice President of Medical Policy, Technology Assessment & Credentialing, WellPoint, Inc.